medicalxpress - Keratin is the fibrous, waterproof protein that builds everything from our hair and nails to a rhino's horn. However, a tiny glitch in it can have problematic outcomes. A new study has found that changes in a keratin gene called KRT16 can lead to a rare c…
AI Summary: Researchers identified keratin 16 (K16) as a molecular brake on skin inflammation: loss of K16 ramps up interferon-driven immune signals, while its presence calms stressed keratinocytes. The discovery points to new targets for inflammatory skin disorders and suggests modulating K16 pathways could yield therapies that actually treat inflammation, not just slap on a cream.
Sanofi ousts Paul Hudson as Belén Garijo named incoming CEO / 3 months
Mid‑stage Parkinson trial failure halts drug development plans / 8 days
Gene therapy pioneers win Breakthrough Prize for CRISPR sickle‑cell work / 6 wks
First-in-human trial primes immune system to accept donor livers / 6 wks
Experimental therapy significantly reduces Parkinson’s toxic protein in early trial / 7 wks
Belzutifan combinations highlighted at ASCO GU improve RCC outcomes / 2 months
FDA lifts holds on Intellia’s Phase 3 gene-editing trials / 2 months
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.